The oral LG/TD-NF consistently reduced blood glucose levels, with accumulated glucose-lowering impacts maintaining HbA1c levels comparable to the subcutaneous LG
During shortages of Wegovy, Ozempic, Mounjaro, and Zepbound, the FDA exercised temporary enforcement discretion , allowing compounding pharmacies to help meet patient demand. Once manufacturing stabilized: Semaglutide injection products were removed from the FDA Drug Shortage List Tirzepatide injection products were formally declared resolved Compounding reverted to pre-shortage federal and state limits Broad, shortage-based compounding is no longer allowed in 2026
a) reacting compound of formula-8 with compound of formula- 10 in a solvent optionally in presence of a coupling agent and/or a base to provide compound of formula-11, b) reacting compound of formula- 11 with compound of formula- 10 in a solvent optionally in presence of a coupling agent and/or a base to provide compound of formula- 13, c) optionally purifying compound of formula- 13, d) treating compound of formula- 13 with compound of formula- 14 Formula- 14 wherein, 'R 1 is as defined above
You can read the full article at Habib AM, Elsherbeny AG, Almehizia RA